Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer

International Journal of Cancer

Volumn 80, Issue 6, 1999, Pages 810-817

  Giatromanolaki, Alexandra ^a,b   Koukourakis, Michael I ^a,b   Georgoulias, Vassilis ^b   Gatter, Kevin C ^a,c   Harris, Adrian L ^a,c   Fountzilas, George ^d  

^a Tumour and Angiogenesis Research Group Iraklion   (Greece)

^b UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHEMOSENSITIVITY; CONTROLLED STUDY; DISEASE ASSOCIATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION RESPONSE; SQUAMOUS CELL CARCINOMA; TISSUE OXYGENATION; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

EID: 0033559523     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990315)80:6<810::AID-IJC3>3.0.CO;2-J     Document Type: Article

References (34)

1. ALBO, D., GRANICK, M.S., JHALA, N., ATKINSON, B. and SOLOMON, M.P., The relationship of angiogenesis to biological activity in human squamous cell carcinoma of the head and neck. Ann. plast. Surg., 32, 588-594 (1994).
2. BROXTERMAN, H.J., LANKELMA, J. and PINEDO, H.M., How to probe clinical tumor samples for p-glycoprotein and multidrug resistance-associated protein. Europ. J. Cancer, 32, 1024-1033 (1996).
3. CARRAU, R.L., BARNES, E.L., SNYDERMAN, C.H., PERTUZZELLI, G., KACHMAN, K., RUEGER, R., D'AMICO, F. and JOHNSON, J.T., Tumour angiogenesis as a predictor of tumour aggressiveness and metastatic potential in squamous cell carcinoma of the head and neck. Invasion Metastasis, 15, 197-202 (1995).
4. FOLKMAN, J., Vascularisation of tumours. Sci. Amer., 234, 58-73 (1976).
5. FONTANINI, G., LUCCHI, M., VIGNATI, S., MUSSI, A., CIARDIELLO, F., DE LAURENTIIS, M., DE PLACIDO, S., BASOLO, F., ANGELETTI, A. and BEVILACQUA, G., Angiogenesis as a prognostic indicator in non-small cell lung carcinoma: a prospective study. J. nat. Cancer Inst., 89, 881-886 (1997).
6. FOUNTZILAS, G., KOSMIDIS, P., AVRAMIDIS, V., NIKOLAOU, A., KALOGERA-FOUNTZILA, A., MAKRANTONAKIS, P., BACOYIANNIS, C., SAMANTAS, E., SKARLOS, D. and DANIILIDIS, J., Long term survival and prognostic factors of a complete response to chemotherapy in patients with head-neck cancer treated with platinum-based induction chemotherapy: a Hellenic Cooperative Oncology Group Study. Med. Pediatr. Oncol., 28, 401-410 (1997).
7. FOWLER, J.F., The phantom of tumour treatment-continually rapid proliferation unmasked. Radiother. Oncol., 22, 156-158 (1991).
8. GASPARINI, G., WEIDNER, N., MALUTA, S., POZZA, P., BORACCHI, P., MAZZETTI, M., TESTOLIN, A. and BEVILACQUA, P., Intratumoural microvessel density and p53 protein: correlation with metastasis in head and neck squamous cell carcinoma. Int. J. Cancer, 55, 739-744 (1993).
9. GIATROMANOLAKI, A., KOUKOURAKIS, M., O'BYRNE, K., FOX, S., WHITEHOUSE, R., TALBOT, D., HARRIS, A.L. and GATTER, K.C., Prognostic value of angiogenesis in operable non small cell lung cancer. J. Pathol., 179, 80-88 (1996).
10. GIATROMANOLAKI, A., KOUKOURAKIS, M., THEODOSSIOU, D., BARBATIS, C., HARRIS, A.L. and GATTER, K.C., Comparative evaluation of angiogenesis assessment with anti-factor VIII and anti-CD31 immunostaining in non small cell lung cancer. Clin. Cancer Res., 3, 2493-2500 (1997).
11. GLEICH, L.L., BIDDINGER, P.W., PAVELIC, Z.P. and GLUCKMAN, J.L., Tumour angiogenesis in T1 oral cavity squamous cell carcinoma: role in predicting tumour aggressiveness. Head-Neck, 18, 343-346 (1996).
12. HALDAR, S., BASU, A. and CROCE, C.M., Bcl2 is the guardian of microtubule integrity. Cancer Res., 57, 229-233 (1997).
13. HOCHHAUSER, D. and HARRIS, A.L., The role of topoisomerase IIa and b in drug resistance. Cancer Treat. Rev., 19, 181-194 (1993).
14. HORAK, E.R., LEKK, R., KLENK, N., LEJEUNE, S., SMITH, K., STUART, N., GREENALL, M., STEPNIEWSKA, K. and HARRIS, A.L., Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet, 340, 1120-1124 (1992).
15. KAKEJI, Y., MAEHARA, Y., IKEBE, M. and TEICHER, B.A., Dynamics of tumour oxygenation, CD31 staining and transforming growth factor-beta levels after treatment with radiation or cyclophosphamide in the rat-13762 mammary carcinoma. Int. J. Radiat Oncol. Biol. 37, 1115-1123 (1997).
16. KLIJANIENKO, J., EL NAGGAR, A.K., DE BRAUD, F., RODRIQUEZ PERALTO, J.L., RODRIQUEZ, R., ITZHAKI, M., RUSSO, A., JANOT, F., LUBOINSKI, B. and CVITKOVIC, E., Tumour vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer. 75, 1649-1656 (1995).
17. KOUKOURAKIS, M., HLOUVERAKIS, G., KOSMA, L., SKARLATOS, J., DAMILAKIS, J., GIATROMANOLAKI, A. and YANNAKAKIS, D., The impact of overall treatment time on the results of radiotherapy for non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys., 34, 315-322 (1996).
18. KOUKOURAKIS, M., STEFANAKI, E., GIATROMANOLAKI, A., FRANGIADAKI, C., ARMENAKI, A., GEORGOULIAS, V., KOUMANDAKIS, E., KRANIDIS, A. and HELIDONIS, E., Fractionated carboplatin radiosensitization. A phase I dose escalation study. Amer. J. clin. Oncol. 21, 595-601 (1998).
19. LEE, D.J., COSMATOS, D., MARCIAL, V.A., FU, K.K., ROTMAN, M., COOPER, J.S., ORTIZ, H.G., BEITLER, J.J., ABRAMS, R.A. and CURRAN, W.J., Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int. J. Radiat. Oncol. Biol. Phys., 32, 567-576 (1995a).
20. LEE, D.J., FU, K.K., COOPER, J.S. and WASSERMAN, T.H., End of an era or not? That is the question - in response to Dr. J.M. Brown. Int. J. Radiat. Oncol. Biol. Phys., 32, 883-885 (1995b).
21. LEEDY, D.A., TRUNE, D.R., KRONZ, J.D., WEIDNER, N. and COHEN, J.I., Tumour angiogenesis, the p53 antigen and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol. Head Neck Surg., 111, 417-422 (1994).
22. MASIERO, L., FIGG, W.D. and KOHN, C., New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAl). thalidomide, TNP-470 and interleukin-12. Angiogenesis, 1, 23-35 (1997).
23. MIKAMI, Y., TSUKUDA, M., ITAO, K., ARAI, Y. and ITO, T., Peritumoural angiogenesis in carcinomas of the head and neck. Auris Nasus Larynx, 23, 57-62 (1996).
24. PARUMS, D.V., CORDELL, J.L., MICKLEM, K., HERYET, A.R., GATTER, K.C. and MASON, D.Y., JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol., 43, 752-757 (1990).
25. PAULSEN, T., AAS, T., BØRRESEN, A.L., VARHAUG, J.E., LONNING, P.E. and AKSLEN, L.A., Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer. Int. J. Cancer, 74, 138-140 (1997).
26. PENFOLD, C.N., PARTRIDGE, M., ROJAS, R. and LANGDON, J.D., The role of angiogenesis in the spread of oral squamous cell carcinoma. Brit. J. Oral Maxillofac. Surg., 34, 37-41 (1996).
27. PEZZELLA, F., DI BACCO, A., ANDREOLA, S., NICHOLSON, A.G., PASTORINO, U. and HARRIS, A.L., Angiogenesis in primary lung cancer and lung secondaries. Europ. J. Cancer, 32, 2494-2500 (1996).
28. PROTOPAPA, E., DELIDES, G.S. and REVESZ, L., Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy. Europ. J. Cancer, 29, 1391-1393 (1993).
29. SAUNDERS, M.I., DISCHE, S., BARRETT, A., PARMAR, M.K., HARVEY, A. and GIBSON, D., Randomized multicenter trials of CHART vs. conventional radiotherapy in head-neck and non-small cell lung cancer. An interim report. Brit. J. Cancer, 3, 1455-1462 (1996).
30. SEEGENSCHMIEDT, M.I. and FELDMAN, H.J., Clinical rationale for thermoradiotherapy. In M.I. Seegenschmiedt, P. Fessenden and C.C. Vernon (eds.). Thermo-radiotherapy and thermo-chemotherapy, Vol. 2, pp. 3-24, Springer, Berlin. (1996).
31. SHPITZER, T., CHAIMOFF, M., GAL, R., STERN, Y., FEINMESSER, R. and SEGAL, K., Tumour angiogenesis as a prognostic factor in early oral tongue cancer. Arch. Otolaryngol. Head Neck Surg., 122, 865-868 (1996).
32. THAMES, H.D., RUIFROK, A.C., MILAS, L., HUNTER, N., MASON, K.A., TERRY, N.H., WHITE, R.A., Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism. Int. J. Radiat. Oncol. Biol. Phys., 35, 951-962 (1996).
33. WEIDNER, N. and FOLKMAN, J., Tumour vascularity as a prognostic factor in cancer. In V.T. DeVita, S. Hellman and S.A. Rosenberg (eds.), Cancer; principles and practice of oncology. Pro-updates, Vol. 11, Lippincott-Raven Publishers. Philadelphia, PA (1997).
34. ZÄTTERSTRÖM, U.K., BRUN, E., WILLEN, R., KJELLEN, E. and WENNERBERG, J., Tumour angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head-Neck, 17, 312-318 (1995).